{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:41:21Z","timestamp":1793047281707,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471482"],"award-info":[{"award-number":["81471482"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["14411965400"],"award-info":[{"award-number":["14411965400"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC12016228"],"award-info":[{"award-number":["SHDC12016228"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s10875-018-0568-x","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T02:54:41Z","timestamp":1543460081000},"page":"854-863","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Report of a Chinese Cohort with Activated Phosphoinositide 3-Kinase \u03b4 Syndrome"],"prefix":"10.1007","volume":"38","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinhua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danru","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haili","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9125-8581","authenticated-orcid":false,"given":"Jinqiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,29]]},"reference":[{"issue":"6160","key":"568_CR1","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.1243292","volume":"342","author":"I Angulo","year":"2013","unstructured":"Angulo I, Vadas O, Gar\u00e7on F, Banham-Hall E, Plagnol V, Leahy TR, et al. Phosphoinositide 3-kinase \u03b4 gene mutation predisposes to respiratory infection and airway damage. Science. 2013;342(6160):866\u201371.","journal-title":"Science"},{"issue":"11","key":"568_CR2","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nri.2016.93","volume":"16","author":"CL Lucas","year":"2016","unstructured":"Lucas CL, Chandra A, Nejentsev S, Condliffe AM, Okkenhaug K. PI3K\u03b4 and primary immunodeficiencies. Nat Rev Immunol. 2016;16(11):702\u201314.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"568_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaci.2016.06.021","volume":"139","author":"TI Coulter","year":"2017","unstructured":"Coulter TI, Chandra A, Bacon CM, Babar J, Curtis J, Screaton N, et al. Clinical spectrum and features of activated phosphoinositide 3-kinase delta syndrome: a large patient cohort study. J Allergy Clin Immunol. 2017;139(2):597\u2013606.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"568_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ni.2771","volume":"15","author":"CL Lucas","year":"2014","unstructured":"Lucas CL, Kuehn HS, Zhao F, Niemela JE, Deenick EK, Palendira U, et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110\u03b4 result in T cell senescence and human immunodeficiency. Nat Immunol. 2014;15(1):88\u201397.","journal-title":"Nat Immunol"},{"issue":"4","key":"568_CR5","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.jaci.2017.03.026","volume":"140","author":"AJ Takeda","year":"2017","unstructured":"Takeda AJ, Zhang Y, Dornan GL, Siempelkamp BD, Jenkins ML, Matthews HF, et al. Novel PIK3CD mutations affecting N-terminal residues of p110\u03b4 cause activated PI3K\u03b4 syndrome (APDS) in humans. J Allergy Clin Immunol. 2017;140(4):1152\u20136.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"568_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10875-014-0109-1","volume":"35","author":"HN Hartman","year":"2015","unstructured":"Hartman HN, Niemela J, Hintermeyer MK, Garofalo M, Stoddard J, Verbsky JW, et al. Gain of function mutations of PIK3CD as a cause of primary sclerosing cholangitis. J Clin Immunol. 2015;35(1):11\u20134.","journal-title":"J Clin Immunol"},{"key":"568_CR7","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3389\/fimmu.2018.00543","volume":"9","author":"ME Maccari","year":"2018","unstructured":"Maccari ME, Abolhassani H, Aghamohammadi A, Aiuti A, Aleinikova O, Bangs C, et al. Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase \u03b4 syndrome: the European Society for Immunodeficiencies-Activated Phosphoinositide 3-kinase \u03b4 syndrome registry. Front Immunol. 2018;9:543.","journal-title":"Front Immunol"},{"issue":"5","key":"568_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/sji.12103","volume":"78","author":"J Sun","year":"2013","unstructured":"Sun J, Ying W, Liu D, Hui X, Yu Y, Wang J, et al. Clinical and genetic features of 5 Chinese patients with X-linked lymphoproliferative syndrome. Scand J Immunol. 2013;78(5):463\u20137.","journal-title":"Scand J Immunol"},{"issue":"5","key":"568_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1365-3083.2012.02772.x","volume":"76","author":"J Sun","year":"2012","unstructured":"Sun J, Wang Y, Liu D, Yu Y, Wang J, Ying W, et al. Prenatal diagnosis of X-linked chronic granulomatous disease by percutaneous umbilical blood sampling. Scand J Immunol. 2012;76(5):512\u20138.","journal-title":"Scand J Immunol"},{"issue":"3","key":"568_CR10","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jaci.2016.08.028","volume":"139","author":"AE Dulau Florea","year":"2017","unstructured":"Dulau Florea AE, Braylan RC, Schafernak KT, Williams KW, Daub J, Goyal RK, et al. Abnormal B-cell maturation in the bone marrow of patients with germline mutations in PIK3CD. J Allergy Clin Immunol. 2017;139(3):1032\u20135.","journal-title":"J Allergy Clin Immunol"},{"key":"568_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.clim.2018.08.007","volume":"197","author":"Y Luo","year":"2018","unstructured":"Luo Y, Xia Y, Wang W, Li Z, Jin Y, Gong Y, et al. Identification of a novel de novo gain-of-function mutation of PIK3CD in a patient with activated phosphoinositide 3-kinase \u03b4 syndrome. Clin Immunol. 2018;197:60\u20137.","journal-title":"Clin Immunol"},{"issue":"13","key":"568_CR12","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1084\/jem.20112607","volume":"209","author":"DK Finlay","year":"2012","unstructured":"Finlay DK, Rosenzweig E, Sinclair LV, Feijoo-Carnero C, Hukelmann JL, Rolf J, et al. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J Exp Med. 2012;209(13):2441\u201353.","journal-title":"J Exp Med"},{"issue":"5","key":"568_CR13","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1073\/pnas.0510772103","volume":"103","author":"S Kang","year":"2006","unstructured":"Kang S, Denley A, Vanhaesebroeck B, Vogt PK. Oncogenic transformation induced by the p110beta, \u2212gamma, and -delta isoforms of class I phosphoinositide 3-kinase. Proc Natl Acad Sci U S A. 2006;103(5):1289\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"568_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/blood-2010-03-275305","volume":"117","author":"BJ Lannutti","year":"2011","unstructured":"Lannutti BJ, Meadows SA, Herman SE, Kashishian A, Steiner B, Johnson AJ, et al. CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood. 2011;117(2):591\u20134.","journal-title":"Blood"},{"issue":"15","key":"568_CR15","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1038\/onc.2011.394","volume":"31","author":"MV Astle","year":"2012","unstructured":"Astle MV, Hannan KM, Ng PY, Lee RS, George AJ, Hsu AK, et al. AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy. Oncogene. 2012;31(15):1949\u201362.","journal-title":"Oncogene"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-018-0568-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-018-0568-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-018-0568-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T21:01:31Z","timestamp":1659042091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-018-0568-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["568"],"URL":"https:\/\/doi.org\/10.1007\/s10875-018-0568-x","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"21 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}